4.7 Letter

Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis

Ryan M. Barber et al.

Summary: Timely, accurate, and comprehensive estimation of SARS-CoV-2 infection rates are crucial for understanding past infections and transmission risks. This study provided a novel approach to estimate global and location-specific infections, combining data sources and correcting biases for more reliable estimates. The findings show staggering impacts of COVID-19 on the global population, highlighting the importance of continued research and policy responses.

LANCET (2022)

Article Medicine, General & Internal

Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas

Eva Dombi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Clinical Neurology

Neurofibromatosis type 1: a multidisciplinary approach to care

Angela C. Hirbe et al.

LANCET NEUROLOGY (2014)

Article Biochemistry & Molecular Biology

Defective proliferative responses in B lymphocytes and thymocytes that lack neurofibromin

TJ Kim et al.

MOLECULAR IMMUNOLOGY (2002)